ElsaLys Biotech
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Evaluation of EFficacy and SaFEty of Leukotac (Inolimomab) in Pediatric Patients With SR-aGvHD (NCT04289103) | ElsaLys Biotech | 2021-10-01 |
Track ElsaLys Biotech automatically
Every clearance here is in the API, with alerts when new ones post.